Sans Atxer, L., & Joly, D. (2018). Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: Patient selection and special considerations.
Citación estilo ChicagoSans Atxer, Laia, y Dominique Joly. Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease: Patient Selection and Special Considerations. 2018.
Cita MLASans Atxer, Laia, y Dominique Joly. Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease: Patient Selection and Special Considerations. 2018.
Precaución: Estas citas no son 100% exactas.